Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Hiv/Aids Therapeutics Market Research Reports

Titlepublishedprice

HIV-associated Lipodystrophy - Market Insights, Epidemiology and Market Forecast-2023

By Delve Insight
"...... ort covers the therapeutics market revenue; average cost of therapy, treatment practice and HIV-associated Lipodystrophy forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global fore......"
01-Nov-2016$4950

HIV-associated Lipodystrophy- Market Insights, Epidemiology and Market Forecast-2023

By Delve Insight
"...... ort covers the therapeutics market revenue; average cost of therapy, treatment practice and HIV-associated Lipodystrophy forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global fore......"
01-Nov-2016$4950

HIV / AIDS-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... derstand the market and pipeline status of the drugs around the HIV / AIDS to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight's Report provide......"
01-Nov-2016$2000

HIV / AIDS-API Insights, 2016

By Delve Insight
"...... market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process......"
01-Nov-2016$1250

AIDS - Related Kaposi's Sarcoma-Pipeline Insights, 2016

By Delve Insight
"...... uding Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, pate......"
01-Nov-2016$1250

HIV-2 Infection-Pipeline Insights, 2016

By Delve Insight
"...... ND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations ......"
01-Nov-2016$1250

HIV-Associated Lipodystrophy Syndrome-Pipeline Insights, 2016

By Delve Insight
"...... lopment including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fu......"
01-Nov-2016$1250

HIV - Epidemiology Forecast To 2023

By Delve Insight
"...... ex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with the HIV. The report is built using data and information sourced from proprietary databases, p......"
01-Nov-2016$2750

Global HIV Partnering 2010 to 2016

By Current Partnering
"...... /> • Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreeme......"
01-Nov-2016$1495

HIV / AIDS - Pipeline Review, H1 2016

By Global Markets Direct
"...... , mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additio......"
30-Jun-2016$2500

Avail upto 50% Discount on below Publisher Reports.